MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS) trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new drug nip multiple myeloma in the bud?
Disease control Recruiting nowThis study tests an investigational drug called linvoseltamab in 116 people with precancerous blood conditions (high-risk MGUS or non-high-risk smoldering multiple myeloma) that raise the risk of developing multiple myeloma. The goal is to see if the drug can eliminate abnormal p…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Simple blood test could catch myeloma years earlier in High-Risk groups
Diagnosis Recruiting nowThis study aims to find multiple myeloma at its earliest, precancerous stage (MGUS) in people at higher risk—Black adults and those with a family history of plasma cell disorders. By screening with a simple blood test, researchers hope to catch the disease before it causes seriou…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Wake Forest University Health Sciences • Aim: Diagnosis
Last updated May 14, 2026 12:05 UTC
-
New study aims to predict who will develop multiple myeloma
Knowledge-focused Recruiting nowThis study looks at 60 people with early blood conditions (MGUS or SMM) that can sometimes turn into multiple myeloma, a type of blood cancer. Researchers will use advanced genetic and immune testing to find clues that predict progression. The goal is to better identify high-risk…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 05:30 UTC
-
Massive study aims to unlock secrets of early blood cancers
Knowledge-focused Recruiting nowThis study looks at genetic changes in people with early-stage blood cancers or conditions that may lead to cancer. Researchers want to understand why some cases progress and others don't. Participants provide extra blood, bone marrow, or cheek swab samples during routine care. N…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated May 26, 2026 05:26 UTC